论文部分内容阅读
1978年,根据广大工农兵病员的要求,从使用方便,安全有效等方面考虑,吴县制药厂将结晶糜胰蛋白酶的结晶或重结晶母液及0.65饱和度沉淀部分提取制成糜胰蛋白酶肠溶片,于1979年5月由江苏省卫生局药政科审批并安排该药的临床。为了验证糜胰蛋白酶片对各种炎症、炎性水肿、血肿、粘连、溃疡等疾病的确切疗效,在注射用结晶糜胰蛋白酶的临床基础上,经临床组长单位苏州地区医院和研制单位吴县制药厂共同研究,拟定了糜胰蛋白酶片
In 1978, according to the requirements of the broad masses of workers and peasants soldiers, from the use of convenient, safe and effective considerations, Wuxian pharmaceutical crystallization or crystallization of crystallization of trypsin crystallization of the mother liquor and 0.65 saturation precipitation was extracted into minced trypsin enteric-coated tablets , In May 1979 by the Jiangsu Provincial Department of Health Pharmaceutical Administration approved and arranged for the clinical medicine. In order to verify the exact role of minced trypsin tablets on various inflammation, inflammatory edema, hematoma, adhesions, ulcers and other diseases in clinical on the basis of injection of crystalline trypsin, the clinical team leader unit Suzhou Hospital and development unit Wuxian Pharmaceutical companies work together to develop a piece of trypsin protease